Molecular targets for treatment of inflammatory breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2009.73.pdf
Reference74 articles.
1. Gonzalez-Angulo, A. M. et al. Trends for inflammatory breast cancer: is survival improving? Oncologist 12, 904–912 (2007).
2. Hance, K. W. et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J. Natl Cancer Inst. 97, 966–975 (2005).
3. Yang, C. H. & Cristofanilli, M. The role of p53 mutations as a prognostic factor and therapeutic target in inflammatory breast cancer. Future Oncol. 2, 247–255 (2006).
4. Colpaert, C. G. et al. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br. J. Cancer 88, 718–725 (2003).
5. Van der Auwera, I. et al. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin. Cancer Res. 10, 7965–7971 (2004).
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The interplay of inflammation and remodeling in the pathogenesis of chronic rhinosinusitis: current understanding and future directions;Frontiers in Immunology;2023-09-12
2. ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer;Frontiers in Oncology;2022-05-05
3. 3D Microphysiological System‐Inspired Scalable Vascularized Tissue Constructs for Regenerative Medicine;Advanced Functional Materials;2021-08-26
4. New Treatment Strategies for the Inflammatory Breast Cancer;Current Treatment Options in Oncology;2021-04-24
5. Hemoglobin overexpression and splice signature as new features of inflammatory breast cancer?;Journal of Advanced Research;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3